| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $244.6M | +15.9% |
| Cost of Revenue | $193.2M | +0.6% |
| Gross Profit | $51.4M | +170.7% |
| R&D Expense | $119.1M | +82.7% |
| SG&A Expense | $110.3M | +23.9% |
| Operating Income | -$177.9M | -31.6% |
| Pre-tax Income | -$178.9M | -34.6% |
| Income Tax | $3.6M | +21.7% |
| Net Income | -$182.6M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $162.5M | -33.0% |
| Short-term Investments | $82.3M | -64.1% |
| Accounts Receivable | $35.2M | -3.8% |
| Inventory | $107.9M | +16.9% |
| Current Assets | $476.7M | -28.0% |
| Total Assets | $941.2M | -4.8% |
| Current Liabilities | $223.4M | +37.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$98.9M | +7.2% |
| Capital Expenditures | $54.7M | +29.0% |
| Investing Cash Flow | $12.0M | +103.5% |
| Financing Cash Flow | $7.4M | +261.0% |
| Free Cash Flow | -$153.6M | -3.1% |
| -34.3% |
| EPS (Basic) | -$0.38 | -31.0% |
| EPS (Diluted) | -$0.38 | -31.0% |
| Long-term Debt |
| $110.0M |
| +10.0% |
| Total Liabilities | $386.7M | +22.4% |
| Stockholders' Equity | $554.5M | -17.6% |